Citation 21223

OKUDA,T: KIMURA,Y: YOSHIDA,T: HATANO,T: OKUDA,H: ARICHI,S:. (1983). STUDIES ON THE ACTIVITIES OF TANNINS AND RELATED COMPOUNDS FROM MEDICINAL PLANTS AND DRUGS. I. INHIBITORY EFFECTS OF LIPID PEROXIDATION IN MITOCHONDRIA AND MICROSOMES OF LIVER.. 31(5)

Citation Details

Title	STUDIES ON THE ACTIVITIES OF TANNINS AND RELATED COMPOUNDS FROM MEDICINAL PLANTS AND DRUGS. I. INHIBITORY EFFECTS OF LIPID PEROXIDATION IN MITOCHONDRIA AND MICROSOMES OF LIVER.
Authors	OKUDA,T: KIMURA,Y: YOSHIDA,T: HATANO,T: OKUDA,H: ARICHI,S:
Year	1983
Volume	31
Issue	5

Summary

Year: 1983

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEDUNCULAGIN	ACTIVE
2	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEDUNCULAGIN	ACTIVE
3	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCOSE,PENTA-O-GALLOYL:	ACTIVE
4	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCOSE,PENTA-O-GALLOYL:	ACTIVE
5	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TERCHEBIN,ISO:	ACTIVE
6	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TERCHEBIN,ISO:	ACTIVE
7	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GEMIN A	ACTIVE
8	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GEMIN A	ACTIVE
9	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHEBULAGIC ACID	ACTIVE
10	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHEBULAGIC ACID	ACTIVE
11	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLATE,EPI: GALLOCATECHIN-(-):	ACTIVE
12	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLATE,EPI: GALLOCATECHIN-(-):	ACTIVE
13	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AGRIMONIIN	ACTIVE
14	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AGRIMONIIN	ACTIVE
15	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROSININ	ACTIVE
16	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROSININ	ACTIVE
17	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GERANIIN,DEHYDRO:	ACTIVE
18	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GERANIIN,DEHYDRO:	ACTIVE
19	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TELLIMAGRANDIN I	ACTIVE
20	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TELLIMAGRANDIN I	ACTIVE
21	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
22	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
23	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TELLIMAGRANDIN II	ACTIVE
24	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TELLIMAGRANDIN II	ACTIVE
25	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TANNIN 1,SS:	ACTIVE
26	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TANNIN 1,SS:	ACTIVE
27	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TANNIN H,RSF:	ACTIVE
28	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TANNIN H,RSF:	ACTIVE
29	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID METHYL ESTER	ACTIVE
30	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID METHYL ESTER	ACTIVE
31	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GERANIIN	ACTIVE
32	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GERANIIN	ACTIVE
33	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	ACTIVE
34	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	ACTIVE
35	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORILAGIN	ACTIVE
36	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORILAGIN	ACTIVE
37	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHEBULINIC ACID	ACTIVE
38	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHEBULINIC ACID	ACTIVE
39	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALNUSIIN	ACTIVE
40	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALNUSIIN	ACTIVE
41	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MALLOTUSINIC ACID	ACTIVE
42	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MALLOTUSINIC ACID	ACTIVE
43	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID	ACTIVE
44	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID	ACTIVE
45	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	ACTIVE
46	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	ACTIVE
47	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID,3-3'-DI-O-METHYL:	INACTIVE
48	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID,3-3'-DI-O-METHYL:	INACTIVE
49	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOCOPHEROL,ALPHA:	WEAK ACTIVITY
50	LIPID PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOCOPHEROL,ALPHA:	WEAK ACTIVITY

Citation 21223

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1